Benzamide ligands for the thyroid receptor

Details for Australian Patent Application No. 2001268132 (hide)

Owner Bristol-Myers Squibb Company

Inventors Ryono, Denis, E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001268132

PCT Pub. Number WO01/94293

Priority 60210102 07.06.00 US

Filing date 1 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 18 May 2006

International Classifications

C07C 235/52 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Event Publications

18 May 2006 Application Accepted

  Published as AU-B-2001268132

21 September 2006 Standard Patent Sealed

6 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001268133-Alpha-fetoprotein peptides and uses thereof

2001268131